Jonathan B. Siegel's most recent trade in Jaguar Health Inc was a trade of 18,262 Warrant to Purchase Common Stock done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 18,262 | 9,000 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 9,462 | 9,462 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2025 | 9,000 | 0 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 9,000 | 9,000 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 9,000 | 9,000 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 26,500 | 26,500 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 68,568 | 69,874 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,145 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 1,145 | 1,306 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 12,133 | 12,133 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2022 | 12,133 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 85,900 | 85,900 | - | - | Restricted stock units | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 72,750 | 72,750 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Jonathan B. Siegel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 36,400 | 36,400 | - | - | Restricted stock units |